Article Versions Notes

Hu C, Zhou Y, Meng X, Li J, Chen J, Ying Z, Xie XS, Hu Y, Cao Y, Jin R. Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial. Pharmaceutics. 2025; 17(1):43. https://doi.org/10.3390/pharmaceutics17010043

Hu, Chaoying, Yibo Zhou, Xing Meng, Jianhua Li, Jinxia Chen, Zhifang Ying, Xiaoliang Sunney Xie, Yaling Hu, Yunlong Cao, and Ronghua Jin. 2025. "Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial" Pharmaceutics 17, no. 1: 43. https://doi.org/10.3390/pharmaceutics17010043

Hu, C., Zhou, Y., Meng, X., Li, J., Chen, J., Ying, Z., Xie, X. S., Hu, Y., Cao, Y., & Jin, R. (2025). Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial. Pharmaceutics, 17(1), 43. https://doi.org/10.3390/pharmaceutics17010043